Aytu Biopharma (AYTU) Net Equity Issued and Repurchased (2010 - 2023)
Aytu Biopharma (AYTU) posted quarterly Net Equity Issued and Repurchased of -$10.1 million for Q2 2023, down 905.17% year-over-year from $1.3 million in Q2 2022, and down 802.71% quarter-over-quarter from $1.4 million in Q1 2023.
Aytu Biopharma (AYTU) Net Equity Issued and Repurchased (2010 - 2023) Analysis & Trends
Aytu Biopharma (AYTU) has reported Net Equity Issued and Repurchased for 10 consecutive years, with -$10.1 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Net Equity Issued and Repurchased fell 905.17% year-over-year to -$10.1 million; the TTM figure through Mar 2024 stood at -$9.7 million (down 175.46% YoY), while the FY2023 annual figure was $2.9 million, down 75.2% from the prior year.
- Net Equity Issued and Repurchased eased to -$10.1 million in Q2 2023 per AYTU's latest filing, from $1.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $12.8 million in Q2 2021 and bottomed at -$10.1 million in Q2 2023.
- Historically, Net Equity Issued and Repurchased has averaged $2.3 million across 3 years, with a median of $1.4 million in 2023.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 81.73% in 2023 and fell as far as 905.17% in 2023.
- Aytu Biopharma's Net Equity Issued and Repurchased stood at $4.5 million in 2021, then slumped by 122.27% to -$1.0 million in 2022, then slumped by 905.17% to -$10.1 million in 2023.
- Business Quant data shows AYTU's Net Equity Issued and Repurchased at -$10.1 million in Q2 2023, $1.4 million in Q1 2023, and -$1.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -10.11 Mn |
| Jun 30, 2023 | -10.11 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Jun 30, 2022 | -1.01 Mn |
| Jun 30, 2022 | -1.01 Mn |
| Mar 31, 2022 | 7.88 Mn |
| Mar 31, 2022 | 7.88 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Sep 30, 2021 | 307,000.00 |
| Sep 30, 2021 | 307,000.00 |
| Jun 30, 2021 | 12.80 Mn |
| Jun 30, 2021 | 12.80 Mn |
| Jun 30, 2018 | -12.90 Mn |
| Jun 30, 2018 | -12.90 Mn |
| Mar 31, 2018 | 12.90 Mn |
| Mar 31, 2018 | 12.90 Mn |
| Sep 30, 2017 | 11.84 Mn |
| Sep 30, 2017 | 11.84 Mn |